MGST1 facilitates novel KRASG12D inhibitor resistance in KRASG12D-mutated pancreatic ductal adenocarcinoma by inhibiting ferroptosis
Chungui Xu, Weihao Lin, Qi Zhang, Yarui Ma, Xue Wang, Ai Guo, Guiling Zhu, Zhendiao Zhou, Weiwei Song, Ziyi Zhao, Yuchen Jiao, Xiaobing Wang, Chunxia Du · 2024
Read MGST1 facilitates novel KRASG12D inhibitor resistance in KRASG12D-mutated pancreatic ductal adenocarcinoma by inhibiting ferroptosis by Chungui Xu, Weihao Lin, Qi Zhang, Yarui Ma, Xue Wang, Ai Guo, Guiling Zhu, Zhendiao Zhou, Weiwei Song, Ziyi Zhao, Yuchen Jiao, Xiaobing Wang, Chunxia Du (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11536589.txt.
Description
Xu and co-authors traced drug resistance in pancreatic cancer for this study from twenty twenty-four. A new drug blocks the KRAS G12D driver found in many of these tumors. Resistance emerges fast, as with other targeted drugs. The team built resistant cell lines and hunted the escape route.
Gene scans pointed at ferroptosis, an iron-driven cell death the drug normally triggers. A detox enzyme, MGST1, stood guard in resistant cells by blocking fat damage. Raising or lowering the enzyme dialed resistance up or down. A growth pathway upstream kept the enzyme switched on. Adding a blocker of that pathway restored the drug's punch in cells and in mice. The pairing is offered as a rescue strategy.
Catalog record
| CREATOR | Chungui Xu, Weihao Lin, Qi Zhang, Yarui Ma, Xue Wang, Ai Guo, Guiling Zhu, Zhendiao Zhou, Weiwei Song, Ziyi Zhao, Yuchen Jiao, Xiaobing Wang, Chunxia Du |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 73 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |